Synonym:
2,5-Dimethylcelecoxib,
4-[5-(2,5-dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide
Properties:
| Related Categories |
Analytical Standards,
Analytical/Chromatography,
Opiates / Synthetic Analgesic Drug Standards,
Pharmaceuticals, Illicit Drugs & Alcohol
|
|
grade
|
analytical standard
|
|
InChI Key
|
NTFOSUUWGCDXEF-UHFFFAOYSA-N
|
|
product line
|
VETRANAL™
|
|
form
|
neat
|
|
shelf life
|
limited shelf life, expiry date on the label
|
|
application(s)
|
HPLC: suitable
|
|
|
gas chromatography (GC): suitable
|
|
format
|
neat
|
|
storage temp.
|
2-8°C
|
Description:
Application
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
Biochem/physiol Actions
Celecoxib, and the inactive analog 2′,5′-dimethyl celecoxib both induce apoptosis in a many cancer cell lines by down-regulating the expression of survivin. This activiy is mediated via an AKT mediated pathway, and is unique to this class of cyclo-oxygenase inhibitors, as non-selective NSAIDs or other COX-2 specific inhibitors such as rofecoxib, do not effect survivin expression. Unlike celecoxib, 2′,5′-dimethyl celecoxib is devoid of any inhibitory activity against COX-2.
Legal Information
VETRANAL is a trademark of Sigma-Aldrich Co. LLC
Safety:
Symbol

GHS06
Precautionary statements
P301 + P310
RIDADR
UN 2811 6.1 / PGIII